The aim of this study is to assess the validity of the 2-minute walk test (2MWT) compared to the 6-minute walk test (TM6) for subjects with onco-hematological disease.
6-minute walk test
2-minutes walk test
10-meters walk test
One leg stance test
Cancer and its treatments have an impact on the body as a whole. The analysis of the subject's physical capacity is essential to know the basic level of the subject pre-treatment, to evaluate progress following rehabilitation, to set goals to prevent decline in physical capacity or to evaluate changes in physical capacity at different stages of survival. The 6-minute walk test (6MWT) is frequently used in the clinic to assess the physical capacity of the subject in oncology. A variant of the 6MWT exists and has been little studied in an oncological context: the 2-minute walk test (2MWT). The 2MWT is performed in the same way as the 6MWT: the same instructions and the same test procedure. It offers the advantage of being less tiring for the test subjects and saves clinicians time. The 2MWT has been validated in the past for people with COPD or after cardiac surgery. To our knowledge, it has not been validated for cancer patients.
|Study Type :||Observational|
|Estimated Enrollment :||56 participants|
|Official Title:||Assessment of Physical Ability in Oncology: a Validation Study of the Two-minute Walk Test|
|Actual Study Start Date :||February 15, 2021|
|Estimated Primary Completion Date :||March 31, 2021|
|Estimated Study Completion Date :||March 31, 2021|
Information not available for Arms and Intervention/treatment
|Ages Eligible for Study:||18 Years|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||No|
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Geneva University Hospitals
Geneva, Switzerland, 1205